BetterLife Pharma Inc. (CSE:BETR)
Canada
· Delayed Price · Currency is CAD 0.0550
-0.0100 (-15.38%)
At close: Dec 5, 2025
BetterLife Pharma Cash Flow Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2020 - 2016 |
| Net Income | -0.84 | -3.52 | -2.89 | -9.02 | -12.16 | -36.35 | Upgrade
|
| Depreciation & Amortization | - | - | - | 0.02 | 0.02 | 0.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.8 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 12.12 | Upgrade
|
| Stock-Based Compensation | 0.5 | 2.05 | 0.5 | 3.94 | 1.35 | 2.18 | Upgrade
|
| Other Operating Activities | -1.94 | -1.3 | -0.41 | 0.12 | 0.91 | 16.9 | Upgrade
|
| Change in Accounts Receivable | 0.02 | 0.03 | -0.02 | 0.31 | 0.18 | -0.35 | Upgrade
|
| Change in Accounts Payable | 0.47 | 0.11 | -0.7 | 2.21 | -1.16 | -0.99 | Upgrade
|
| Change in Income Taxes | - | - | - | -0.16 | 0.17 | - | Upgrade
|
| Change in Other Net Operating Assets | 1.44 | 0.62 | 1.05 | 1.07 | -0.51 | -0.2 | Upgrade
|
| Operating Cash Flow | -0.35 | -2.02 | -2.47 | -1.5 | -11.2 | -7.16 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.09 | Upgrade
|
| Investing Cash Flow | - | - | - | - | - | -0.07 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.6 | Upgrade
|
| Long-Term Debt Issued | - | 1.22 | 0.3 | - | 0.12 | - | Upgrade
|
| Total Debt Issued | 0.03 | 1.22 | 0.3 | - | 0.12 | 0.6 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.25 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -0.5 | Upgrade
|
| Total Debt Repaid | - | - | - | - | -0.25 | -0.5 | Upgrade
|
| Net Debt Issued (Repaid) | 0.03 | 1.22 | 0.3 | - | -0.13 | 0.1 | Upgrade
|
| Issuance of Common Stock | 0.22 | 0.75 | 2.2 | 0.72 | 11.47 | 1.38 | Upgrade
|
| Other Financing Activities | - | 0.02 | - | 0.61 | -0.1 | 2.61 | Upgrade
|
| Financing Cash Flow | 0.24 | 1.99 | 2.5 | 1.34 | 11.23 | 4.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | -0 | 0 | -0.01 | 0.02 | Upgrade
|
| Net Cash Flow | -0.1 | -0.03 | 0.03 | -0.17 | 0.02 | -3.13 | Upgrade
|
| Free Cash Flow | -0.35 | -2.02 | -2.47 | -1.5 | -11.2 | -7.18 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.02 | -0.15 | -0.27 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.48 | Upgrade
|
| Levered Free Cash Flow | -1.64 | -1.65 | -1.84 | 2.13 | -6.18 | 1.51 | Upgrade
|
| Unlevered Free Cash Flow | -1.53 | -1.45 | -1.81 | 2.17 | -6.14 | 1.53 | Upgrade
|
| Change in Working Capital | 1.93 | 0.75 | 0.32 | 3.43 | -1.32 | -1.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.